UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012572
Receipt number R000014709
Scientific Title Iron status affect platelet counts in hemodialysis patients.
Date of disclosure of the study information 2013/12/14
Last modified on 2015/06/14 12:20:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Iron status affect platelet counts in hemodialysis patients.

Acronym

Iron status affect platelet counts in hemodialysis patients.

Scientific Title

Iron status affect platelet counts in hemodialysis patients.

Scientific Title:Acronym

Iron status affect platelet counts in hemodialysis patients.

Region

Japan


Condition

Condition

End stage renal failure on maintenance heamodialysis.

Classification by specialty

Nephrology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We investigated the association between platelet counts and iron reactivity among HD patients.

Basic objectives2

Others

Basic objectives -Others

We examined whether iron depletion was associated with thrombocytosis. Does platelet counts correlate with iron indices? Does platelet counts trends and variability correlate with iron indices? We investigated whether ESAs doses was associated with iron reactivity.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

platelet counts, serum iron, ferritin, transferrin saturation

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Cohort study of HD outpatients followed from 2002 to 2012.

Key exclusion criteria

Exclude hospital patients and data during hospitalization.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kiyomi Koike

Organization

Kurume University School of Medicine

Division name

Division of Nephrology, Department of Medicine

Zip code


Address

67 Asahi-machi, Kurume 830-0011 Japan

TEL

0942-35-3311

Email

koike_kiyomi@kurume-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kiyomi Koike

Organization

Kurume University School of Medicine

Division name

Division of Nephrology, Department of Medicine

Zip code


Address

67 Asahi-machi, Kurume 830-0011 Japan

TEL

0942-35-3311

Homepage URL


Email

koike_kiyomi@kurume-u.ac.jp


Sponsor or person

Institute

Kurume University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kurume University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

久留米大学病院
島松内科医院


Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 14 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2009 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry

2014 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded

2014 Year 12 Month 31 Day


Other

Other related information

This study is retrospective cohort study.Therapy targets for renal anemia were Hb11.0 g/dL and ferritin 200 mg/dL with erythropoietin and protocol for i.v. iron supplementation. We investigate the association between iron indices and increase in platelet counts with mixed effect model with non-linear and linear analysis used regular checkup data.


Management information

Registered date

2013 Year 12 Month 13 Day

Last modified on

2015 Year 06 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014709


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name